Adventris Pharmaceuticals
YC W23Baltimore, US · Founded 2022 · 7 employees · 3 known investors
Adventris is a biotechnology company developing cancer immunotherapy treatments.
Also known as Elimivax
BiotechHealthtechHealthcareTherapeuticsDrug discoveryOncologyUnited States of AmericaAmerica / CanadaPartly Remote
Founders & leadership· Y Combinator alumni (W23)
Adventris Pharmaceuticals was founded in 2022 by Jen Herbach, William Collis, and Mark Yarchoan.
JH
Jen HerbachinCEO & Co-FounderJen Herbach has over a decade of experience in oncology drug development at biotechnology companies including Onyx/Amgen, InterMune/Genentech, Exelixis, and Amunix. She holds an MBA from Harvard Business School and a master's degree from the University of Cambridge.
WC
William Collisin𝕏Co-FounderWilliam Collis previously founded Genji, a data platform. He holds an MBA from Harvard Business School and graduated from Amherst College, where he met co-founders Jen Herbach and Mark Yarchoan.
MY
Mark Yarchoan𝕏FounderMark Yarchoan is an Associate Professor of Medical Oncology at Johns Hopkins with NCI-funded research in immunotherapy development, particularly cancer vaccines. He has conducted clinical trials of immunotherapy agents including neoantigen-targeted approaches.
Investors · 3
Competitors · 2
by search overlap
Alumis4 shared keywordsAlumis is a clinical-stage biopharmaceutical company developing a late-stage portfolio of targeted therapies for immune-mediated diseases. It focuses on small-molecule drug discovery and development in immunology and inflammation.
Zentalis4 shared keywordsZentalis is a biopharmaceutical company developing azenosertib and other pipeline assets, seeking strategic partnerships to advance drug development and expand market reach globally.
Companies competing with Adventris Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Adventris Pharmaceuticals do?
- Adventris is a biotechnology company developing cancer immunotherapy treatments.
- Who founded Adventris Pharmaceuticals?
- Adventris Pharmaceuticals was founded by Jen Herbach, William Collis, Mark Yarchoan in 2022.
- Who are Adventris Pharmaceuticals's investors?
- Adventris Pharmaceuticals's investors include Y Combinator, Illumina Ventures, Refactor Capital.
- Where is Adventris Pharmaceuticals headquartered?
- Adventris Pharmaceuticals is headquartered in Baltimore, US.